
Harvard Bioscience HBIO
$ 6.3
4.3%
Quarterly report 2026-Q1
added 05-12-2026
Harvard Bioscience Depreciation & Amortization 2011-2026 | HBIO
Annual Depreciation & Amortization Harvard Bioscience
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.74 M | 1.73 M | 1.47 M | 1.45 M | 1.78 M | 1.92 M | 1.99 M | 2.42 M | 1.32 M | 1.53 M | 1.74 M | 1.25 M | 1.3 M | 4.21 M | 4.33 M | 3.92 M | 1.2 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 4.33 M | 1.2 M | 2.08 M |
Quarterly Depreciation & Amortization Harvard Bioscience
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 443 K | 855 K | 1.16 M | 451 K | - | 1.33 M | 1.33 M | 404 K | - | 1.36 M | 1.39 M | 333 K | - | 1.57 M | 1.45 M | 382 K | - | 1.46 M | 1.46 M | 445 K | - | 1.45 M | 982 K | 484 K | - | 1.5 M | 972 K | 538 K | - | 1.47 M | 1.05 M | 495 K | - | 1.01 M | 659 K | 306 K | - | 1.17 M | 809 K | 385 K | - | 1.16 M | 769 K | 364 K | - | 913 K | 608 K | 608 K | - | 990 K | 676 K | 357 K | - | 930 K | 622 K | 317 K | - | 969 K | 689 K | 307 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.57 M | 306 K | 857 K |
Depreciation & Amortization of other stocks in the Medical instruments industry
| Issuer | Depreciation & Amortization | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
15.1 K | - | - | $ 810 M | ||
|
The Cooper Companies
COO
|
377 M | $ 67.81 | -1.18 % | $ 13.5 B | ||
|
Glaukos Corporation
GKOS
|
38.1 M | $ 120.74 | -4.5 % | $ 6.91 B | ||
|
Intuitive Surgical
ISRG
|
600 M | $ 420.65 | -1.4 % | $ 150 B | ||
|
ICU Medical
ICUI
|
201 M | $ 142.61 | 0.43 % | $ 3.51 B | ||
|
Repro Med Systems
KRMD
|
810 K | $ 3.98 | -0.5 % | $ 184 M | ||
|
iRhythm Technologies
IRTC
|
20.7 M | $ 115.57 | 1.53 % | $ 3.7 B | ||
|
LeMaitre Vascular
LMAT
|
10.4 M | $ 96.58 | -0.01 % | $ 2.19 B | ||
|
Masimo Corporation
MASI
|
103 M | $ 179.95 | - | $ 9.59 B | ||
|
Microbot Medical
MBOT
|
47 K | $ 1.83 | 0.27 % | $ 83.8 M | ||
|
Ekso Bionics Holdings
EKSO
|
1.57 M | - | - | $ 28.6 M | ||
|
Milestone Scientific
MLSS
|
78.2 K | $ 0.4 | 2.79 % | $ 32.8 M | ||
|
Merit Medical Systems
MMSI
|
123 M | $ 67.15 | -0.54 % | $ 3.97 B | ||
|
electroCore
ECOR
|
501 K | $ 9.84 | 3.36 % | $ 83.5 K | ||
|
Envista Holdings Corporation
NVST
|
116 M | $ 24.65 | 0.24 % | $ 4.14 B | ||
|
Haemonetics Corporation
HAE
|
112 M | $ 79.88 | 1.45 % | $ 3.77 B | ||
|
STERIS plc
STE
|
486 M | $ 211.1 | -0.84 % | $ 20.7 B | ||
|
Isoray
ISR
|
3.25 M | - | 0.03 % | $ 108 M | ||
|
STAAR Surgical Company
STAA
|
8.32 M | $ 29.81 | -0.2 % | $ 1.48 B | ||
|
InfuSystem Holdings
INFU
|
13.3 M | $ 9.13 | 1.11 % | $ 189 M | ||
|
Teleflex Incorporated
TFX
|
178 M | $ 136.49 | 0.55 % | $ 6.09 B | ||
|
Utah Medical Products
UTMD
|
826 K | $ 69.08 | 1.48 % | $ 224 M | ||
|
West Pharmaceutical Services
WST
|
171 M | $ 333.67 | -0.37 % | $ 24.1 B | ||
|
Pulse Biosciences
PLSE
|
406 K | $ 25.05 | -2.79 % | $ 1.69 B | ||
|
DENTSPLY SIRONA
XRAY
|
352 M | $ 10.52 | 0.43 % | $ 2.1 B | ||
|
Retractable Technologies
RVP
|
7.77 M | $ 0.69 | -0.16 % | $ 20.7 M | ||
|
Pro-Dex
PDEX
|
1.24 M | $ 65.1 | 0.15 % | $ 214 M | ||
|
Predictive Oncology
POAI
|
129 K | - | - | $ 31.1 M | ||
|
BioLife Solutions
BLFS
|
2.25 M | $ 27.8 | 0.91 % | $ 1.33 B | ||
|
Stereotaxis
STXS
|
626 K | $ 1.87 | 1.08 % | $ 170 M | ||
|
Baxter International
BAX
|
981 M | $ 20.93 | 4.49 % | $ 10.7 B | ||
|
ResMed
RMD
|
160 M | $ 195.8 | -0.58 % | $ 28.6 B | ||
|
AtriCure
ATRC
|
12.1 M | $ 27.42 | 0.44 % | $ 1.31 B | ||
|
NeuroMetrix
NURO
|
94 K | - | 5.05 % | $ 9.02 M | ||
|
AngioDynamics
ANGO
|
25.8 M | $ 12.47 | 1.05 % | $ 509 M | ||
|
Becton, Dickinson and Company
BDX
|
2.46 B | $ 150.22 | -1.2 % | $ 43.2 B | ||
|
Nephros
NEPH
|
140 K | $ 3.19 | -1.82 % | $ 33.9 M | ||
|
OraSure Technologies
OSUR
|
10.2 M | $ 4.26 | 0.59 % | $ 313 M | ||
|
Repligen Corporation
RGEN
|
78.7 M | $ 134.67 | 3.49 % | $ 7.57 M |